Down 84% From Its High, Is NuScale Power a Bargain Hiding in Plain Sight?

NuScale Power (SMR) shares are down ~84% from ~$57 last October to just under $10, reflecting prolonged skepticism despite progress toward a potential first major deal. A nonbinding agreement could support a 6GW TVA project (up to ~72 modules) with ENTRA1, but revenue timing remains uncertain because a definitive PPA is not yet signed. NuScale has already incurred about $507M for an initial milestone and could face an additional ~$1.2B milestone cost if a PPA is executed, keeping the setup highly speculative.

Analysis

SMR is still trading like a financing event rather than an industrial asset. The market tends to capitalize “design approval + project talk” far faster than it prices in the cash drag of milestone obligations, so a headline win can coexist with worsening equity economics if the project remains non-binding and capital-intensive. In other words, the first meaningful catalyst is not a bigger addressable market; it is proof that third-party financing can absorb the upfront spend without forcing dilution.

The likely near-term winners from any real momentum are not SMR shareholders alone but the adjacent industrial stack: EPC, electrical equipment, and uranium-fuel names such as CCJ and URA proxies, which benefit from incremental credibility around SMR deployment without bearing first-of-a-kind execution risk. Utility counterparties are the choke point; if project economics look inflated, they will slow-walk or rebid terms, which would be bearish for SMR but neutral-to-positive for better-capitalized competitors. The second-order risk is that a visible project can still fail to translate into earnings if milestone cash outflows front-run revenue recognition.

Consensus seems to be treating the stock as “cheap after a washout,” but cheapness only matters if the path to self-funding shortens. The contrarian read is that the downside is not just project failure; it is a long period of headline progress with no EBITDA, no operating reference plant, and recurring dilution risk. The bullish falsifier is a signed PPA paired with transparent, non-dilutive project financing; absent that, this remains a speculative option, not a value recovery.

Key Decisions for Investors

• Do not chase SMR on project headlines alone; require a binding PPA and disclosed financing structure before considering a long, because the market is still pricing cash burn and dilution risk, not near-term earnings.
• Tactically short SMR into strength or buy 1-3 month put spreads if the stock spikes on non-binding TVA progress; thesis breaks if management shows a signed contract plus credible third-party funding that limits equity dilution.
• Pair trade: long URA or CCJ against short SMR to express a nuclear buildout view without taking first-of-a-kind execution and milestone-payment risk at the developer level.
• If a binding PPA lands, switch from bearish to volatility capture: consider call spreads rather than outright shares, since a rerating is likely but the upside remains capped by long-dated commercialization uncertainty.